Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autophagy: novel action of panitumumab in colon cancer.

Anticancer research - 1 Dec 2009

Giannopoulou Efstathia, Antonacopoulou Anna, Matsouka Panagiota, Kalofonos Haralabos P

Abstract excerpt

BACKGROUND: Panitumumab, a fully-human monoclonal antibody raised against epidermal growth factor receptor (EGFR), has been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) for the treatment of patients with EGFR-expressing metastatic colorectal carcinoma (mCRC) after failure of standard chemotherapy. Additionally, the guideline of the EMEA includes the use of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Panitumumab
Share to ras Proteins
Share to Oxidation-Reduction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autophagy

Share to Cell Cycle

Share to Colonic Neoplasms

Share to Glutathione

Share to Immunoblotting

Source

Identifiers

PMID: 20044619

Genes

EGFR
KRAS
DLD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autophagy: novel action of panitumumab in colon cancer.PMID 20044619Read ↗

Mechanism of Pterostilbene-Induced Cell Death in HT-29 Colon Cancer CellsSemantic proximity Read ↗

Morindone as a potential therapeutic compound targeting TP53 and KRAS mutations in colorectal cancer cells.Semantic proximity Read ↗

Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosisSemantic proximity Read ↗

The rational modulation of autophagy sensitizes colorectal cancer cells to 5-fluouracil and OxaliplatinSemantic proximity Read ↗

CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal CancerSemantic proximity Read ↗

Integration of panitumumab into the treatment of colorectal cancer.Semantic proximity Read ↗

3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis.Semantic proximity Read ↗

Origanum majorana Ethanolic Extract Promotes Colorectal Cancer Cell Death by Triggering Abortive Autophagy and Activation of the Extrinsic Apoptotic PathwaySemantic proximity Read ↗

Berberine regulates the microRNA‑21‑ITGΒ4‑PDCD4 axis and inhibits colon cancer viabilitySemantic proximity Read ↗

Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagySemantic proximity Read ↗

Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer.Semantic proximity Read ↗

Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.